Abbott Laboratories (Pakistan) Limited

KASE:ABOT Stock Report

Market Cap: PK₨72.2b

Abbott Laboratories (Pakistan) Past Earnings Performance

Past criteria checks 3/6

Abbott Laboratories (Pakistan)'s earnings have been declining at an average annual rate of -6.5%, while the Pharmaceuticals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 14.4% per year. Abbott Laboratories (Pakistan)'s return on equity is 10.1%, and it has net margins of 3.5%.

Key information

-6.5%

Earnings growth rate

-6.5%

EPS growth rate

Pharmaceuticals Industry Growth20.2%
Revenue growth rate14.4%
Return on equity10.1%
Net Margin3.5%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Abbott Laboratories (Pakistan) makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KASE:ABOT Revenue, expenses and earnings (PKR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2457,6982,0009,3410
31 Dec 2355,4752628,9890
30 Sep 2353,531-3538,6910
30 Jun 2351,8204258,4410
31 Mar 2351,2921,3438,1250
31 Dec 2249,2583,0047,8350
30 Sep 2248,0744,0407,9030
30 Jun 2246,4524,4657,7440
31 Mar 2244,4505,9667,4260
31 Dec 2142,5705,9677,2320
30 Sep 2141,7595,9226,8090
30 Jun 2139,5485,6976,3850
31 Mar 2137,1135,1155,9260
31 Dec 2035,2834,5355,5160
30 Sep 2032,8473,6335,4840
30 Jun 2031,3842,9145,3920
31 Mar 2031,0021,8355,4830
31 Dec 1930,1561,3005,7460
30 Sep 1930,4051,3965,5560
30 Jun 1931,2471,9485,4200
31 Mar 1930,6032,4025,3920
31 Dec 1829,7192,6945,0700
30 Sep 1829,0233,4874,8750
30 Jun 1827,8083,7804,6450
31 Mar 1827,0264,1214,3880
31 Dec 1726,0884,2054,0430
30 Sep 1725,2583,9654,0560
30 Jun 1724,4793,9993,8880
31 Mar 1723,8974,0053,7660
31 Dec 1623,3884,0223,6780
30 Sep 1622,6874,0213,4630
30 Jun 1622,3353,8163,4940
31 Mar 1621,7893,7463,3700
31 Dec 1521,1703,5873,2330
30 Sep 1520,9233,2193,4640
30 Jun 1520,1612,9613,2980
31 Mar 1519,5112,7493,3210
31 Dec 1419,6922,8163,3060
30 Sep 1418,8702,7843,0290
30 Jun 1418,3282,7173,0120
31 Mar 1417,8252,7002,9260
31 Dec 1317,2172,5292,8210
30 Sep 1316,6092,3352,7650

Quality Earnings: ABOT has a high level of non-cash earnings.

Growing Profit Margin: ABOT's current net profit margins (3.5%) are higher than last year (2.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ABOT's earnings have declined by 6.5% per year over the past 5 years.

Accelerating Growth: ABOT's earnings growth over the past year (48.9%) exceeds its 5-year average (-6.5% per year).

Earnings vs Industry: ABOT earnings growth over the past year (48.9%) exceeded the Pharmaceuticals industry 22%.


Return on Equity

High ROE: ABOT's Return on Equity (10.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.